IFN-α inhibits telomerase in human CD8⁺ T cells by both hTERT downregulation and induction of p38 MAPK signaling.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3836248)

Published in J Immunol on August 30, 2013

Authors

Alessio Lanna1, Elias Coutavas, Lauretta Levati, Judith Seidel, Malcolm H A Rustin, Sian M Henson, Arne N Akbar, Ornella Franzese

Author Affiliations

1: Pharmacology Section, Department of System Medicine, University of Rome Tor Vergata, 00133, Rome, Italy;

Articles cited by this

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res (1991) 13.54

The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90

Association between telomere length in blood and mortality in people aged 60 years or older. Lancet (2003) 10.56

Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem (1995) 9.56

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J (2001) 9.40

Telomere length regulation. Annu Rev Biochem (1996) 6.98

Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol (2002) 6.38

Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem (1995) 4.50

Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci (1999) 4.42

Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science (2013) 4.18

Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science (2013) 4.14

Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett (2005) 4.04

Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science (2004) 3.61

Telomeres in T and B cells. Nat Rev Immunol (2002) 2.76

Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci U S A (1999) 2.42

Interferon-induced antiviral actions and their regulation. Adv Virus Res (1993) 2.40

Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem (1999) 2.34

Type I IFN modulates innate and specific antiviral immunity. J Immunol (2000) 2.26

Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol (2007) 2.03

Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol (2005) 1.85

Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol (2001) 1.77

KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 1.73

Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood (2001) 1.71

Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med (2004) 1.71

The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci (2001) 1.70

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68

Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol (2004) 1.58

Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol (2000) 1.53

Telomerase beyond telomeres. Nat Rev Cancer (2002) 1.52

Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol (2011) 1.46

The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol (2007) 1.38

E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res (2001) 1.35

Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology (2011) 1.34

Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood (2004) 1.32

The human thymus during aging. Immunol Res (2000) 1.31

Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res (2003) 1.28

Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem (1997) 1.28

Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol (2004) 1.21

IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J Immunol (2005) 1.19

Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. Blood (2000) 1.17

Inflammation, ageing and cancer. Mech Ageing Dev (2008) 1.12

IFN-α in the treatment of melanoma. J Immunol (2012) 1.12

Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol (2012) 1.09

Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age (Dordr) (2012) 1.06

The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev (2005) 1.01

Ring cycle for dilating and constricting the nuclear pore. Proc Natl Acad Sci U S A (2013) 1.01

Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation. J Cell Sci (2012) 1.01

The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00

Telomerase regulation. Mutat Res (2011) 0.98

The role of telomerase expression and telomere length maintenance in human and mouse. J Clin Immunol (2000) 0.97

Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Oncogene (1999) 0.96

Interferon-α as antiviral and antitumor vaccine adjuvants: mechanisms of action and response signature. J Interferon Cytokine Res (2012) 0.95

Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. J Immunol (2013) 0.95

In vitro senescence of immune cells. Exp Gerontol (2003) 0.89

Second-line systemic therapy for the treatment of metastatic renal cell cancer. Expert Rev Anticancer Ther (2012) 0.87

Microwave-assisted synthesis of N-pyrazole ureas and the p38alpha inhibitor BIRB 796 for study into accelerated cell ageing. Org Biomol Chem (2006) 0.86

Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes. PLoS One (2011) 0.84

Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database Syst Rev (2010) 0.81

Interferon-induced sensitization to apoptosis is associated with repressed transcriptional activity of the hTERT promoter in multiple myeloma. Biochem Biophys Res Commun (2006) 0.79

Update on PEG-interferon α-2b as adjuvant therapy in melanoma. Anticancer Res (2012) 0.78

Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes. Mol Immunol (2012) 0.77

Articles by these authors

Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest (2006) 3.25

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther (2005) 3.17

CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol (2009) 2.66

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol (2005) 2.53

Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain. J Immunol (2004) 2.49

Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol (2002) 2.18

Features of immune senescence in liver transplant recipients with established grafts. Liver Transpl (2010) 2.05

Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol (2011) 1.93

Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol (2005) 1.85

KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 1.73

Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med (2004) 1.71

Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol (2010) 1.66

Rae1 interaction with NuMA is required for bipolar spindle formation. Proc Natl Acad Sci U S A (2006) 1.55

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med (2008) 1.54

Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol (2011) 1.46

The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest (2008) 1.46

Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol (2010) 1.42

The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol (2007) 1.38

Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology (2011) 1.34

Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med (2009) 1.29

Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J Immunol (2003) 1.29

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest (2005) 1.26

Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Mol Cell (2012) 1.19

CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 1.17

CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol (2005) 1.16

p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells. J Clin Invest (2014) 1.13

Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood (2002) 1.13

Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology (2006) 1.12

Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol (2003) 1.11

Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol (2006) 1.10

Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol (2012) 1.09

KLRG1--more than a marker for T cell senescence. Age (Dordr) (2009) 1.08

Mantoux Test as a model for a secondary immune response in humans. Immunol Lett (2006) 1.07

Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am J Clin Nutr (2004) 1.07

AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. Mol Pharmacol (2008) 1.06

Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res (2007) 1.05

The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev (2005) 1.01

Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection. Blood (2005) 1.00

Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol (2010) 1.00

The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00

Translational research in immune senescence: assessing the relevance of current models. Semin Immunol (2012) 1.00

Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol (2007) 0.99

Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology (2006) 0.99

Immune responses in the skin in old age. Curr Opin Immunol (2011) 0.98

Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: contributor to exhaustion? J Infect Dis (2008) 0.98

Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans. J Immunol (2013) 0.97

Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology (2010) 0.97

Cytokine-mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from protein kinase B activation. Eur J Immunol (2002) 0.97

Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. J Immunol (2013) 0.95

CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection. J Hepatol (2010) 0.93

Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. Invest Ophthalmol Vis Sci (2002) 0.93

Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res (2004) 0.92

Women living with facial hair: the psychological and behavioral burden. J Psychosom Res (2006) 0.91

Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells. J Cell Sci (2002) 0.89

Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection. Blood (2003) 0.88

Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis. J Immunol (2004) 0.88

Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano (2014) 0.87

Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis? Trends Immunol (2004) 0.86

Reconstitution of nuclear protein export in isolated nuclear envelopes. J Cell Biol (2002) 0.86

Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. Int J Oncol (2005) 0.85

Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade. Immunology (2012) 0.84

Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells. Int Immunol (2012) 0.83

The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound. Pharmacol Res (2009) 0.82

My T's gone cold, I'm wondering why. Nat Immunol (2003) 0.82

Telomere-based therapy for immunosenescence. Trends Immunol (2002) 0.82

Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin. Int J Cancer (2014) 0.81

Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am J Clin Nutr (2007) 0.81

Multiscale three-dimensional scaffolds for soft tissue engineering via multimodal electrospinning. Acta Biomater (2009) 0.81

The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro. J Exp Clin Cancer Res (2013) 0.80

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug. J Transl Med (2012) 0.80

Nuclear transport kinetics in microarrays of nuclear envelope patches. J Struct Biol (2002) 0.80

Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors. Oncol Rep (2010) 0.79

Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis. Apoptosis (2008) 0.79

Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor. Mol Pharmacol (2003) 0.79

Measurement of proliferation and disappearance of regulatory T cells in human studies using deuterium-labeled glucose. Methods Mol Biol (2011) 0.79

Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element. Hum Mutat (2015) 0.79

Exacerbation of X-linked ichthyosis phenotype in a female by inheritance of filaggrin and steroid sulfatase mutations. J Dermatol Sci (2011) 0.78

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. Biochem Pharmacol (2012) 0.78

Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults. Immunology (2015) 0.78